LUMIRA VENTURES
With a 30-year reputation as a leading North American healthcare and life sciences venture capital firm, with offices in Toronto, Montreal, Vancouver and Boston, Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide. Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.
LUMIRA VENTURES
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Information Technology Medical Medical Device Pharmaceutical Therapeutics Venture Capital
Founded:
1989-01-01
Status:
Active
Contact:
416.213.4223
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache
Similar Organizations
ABC Compounding Pharmacy
ABC Compounding Pharmacy is guaranteed to meet and exceed your expectations by providing quality service at low convenient pricing.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Chicago Prostate Cancer Center
Specialize in the diagnosis treatment of prostate cancer with radiation seed implants. #Brachytherapy #Prostate #Cancer
Chugai Pharma USA
Chugai Pharma USA is a healthcare based pharmaceutical firm providing products and services for the benefit of patients.
HealthWright Technologies
HealthWright Technologies is a healthcare service provider & pharmaceutical firm that provides healthcare technology & patient services.
InVitro Select
Innovative system to increase the success rate of vitro fertilization (IVF) by selecting the most viable sperm for the procedure.
Leo Universal
Leo Universal is a Chinese company that engaged in coal processing, logistic transportation networks and childhood education.
NeoProteomics
NeoProteomics provides research services and tools that help clients unravel the complexities of pharmaceutical and biological research.
Orion Modern
An innovative healthcare venture capital firm. Genetics, pharma and wider biotech. America & Asia HQ. Founded in 2010.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Plexigen
Plexigen develops a proprietary 3-D biochip to significantly enhance the capacity, efficiency, accuracy, and automation of gene screening.
PTM BioLab
PTM Biolab addresses the need for life sciences and personalized medicine, by the creation and supply of innovative technologies.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-30 | X4 Pharmaceuticals | Lumira Ventures investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
| 2022-02-08 | Congruence Therapeutics | Lumira Ventures investment in Series A - Congruence Therapeutics | 63 M CAD |
| 2021-12-16 | Specific Biologics | Lumira Ventures investment in Seed Round - Specific Biologics | N/A |
| 2021-12-09 | OncoMyx Therapeutics | Lumira Ventures investment in Series B - OncoMyx Therapeutics | 50 M USD |
| 2021-12-08 | Viron Inc. | Lumira Ventures investment in Series B - Viron Inc. | 50 M USD |
| 2021-11-03 | Antios Therapeutics | Lumira Ventures investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-11-02 | Antiva Biosciences | Lumira Ventures investment in Series D - Antiva Biosciences | 31 M USD |
| 2021-10-29 | Deka Biosciences | Lumira Ventures investment in Series A - Deka Biosciences | 20 M USD |
| 2021-08-10 | Thryv Therapeutics | Lumira Ventures investment in Series A - Thryv Therapeutics | 19 M USD |
| 2021-05-20 | BioTheryX | Lumira Ventures investment in Series E - BioTheryX | 92 M USD |
Newest Events participated
Participated in proTECH 2019
on 2019-10-10 as speaker